USP4 and rheumatic heart disease: Increased mRNA levels of USP4 and IL-17, but not of RORγt, were detected in CD4+ T cells from patients with rheumatic heart disease, indicating that USP4 could serve as a therapeutic target in Th17-driven autoimmune disorders.590